PhotoPharmics https://photopharmics.com/ A New Therapy for Neurodegenerative Diseases Tue, 20 Jan 2026 13:59:50 +0000 en-US hourly 1 https://wordpress.org/?v=6.9 https://photopharmics.com/wp-content/uploads/2017/04/cropped-icon-32x32.png PhotoPharmics https://photopharmics.com/ 32 32 PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company’s Phase 3/Pivotal Clinical Trial https://photopharmics.com/photopharmics-announces-publication-of-phase-2-clinical-trial-results-in-neurotherapeutics/ Tue, 20 Jan 2026 13:00:35 +0000 https://photopharmics.com/?p=6444 PhotoPharmics, Inc. today announced the peer-reviewed publication of results from its Phase 2 randomized, double-blind, controlled clinical trial evaluating Celeste®, an investigational photo-neuromodulation device, in people living with Parkinson’s disease (PD). The study has been published in the journal Neurotherapeutics. Celeste® has been designated by the U.S. Food and Drug Administration as a Breakthrough Device.

The publication marks an important scientific milestone for the Company and contributes to the growing body of clinical evidence examining circadian-effective photo-neuromodulation in PD. The Phase 2 findings informed the design of the Company’s ongoing Phase 3/Pivotal trial, which is fully enrolled and expected to complete in Q2 2026.

The Phase 2 study evaluated daily photo-neuromodulation delivered via a patented spectral band of light frequencies designed to engage circadian pathways.  The trial assessed both motor and non-motor features in individuals with PD receiving standard-of-care therapies. Celeste was well tolerated over the six-month period, with no serious adverse events reported.

The post PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company’s Phase 3/Pivotal Clinical Trial appeared first on PhotoPharmics.

]]> Understanding Parkinson’s Fatigue https://photopharmics.com/understanding-parkinsons-fatigue/ Wed, 24 Dec 2025 02:46:55 +0000 https://photopharmics.com/?p=6433 Introduction Imagine waking up after a full night’s sleep, yet feeling as though you haven’t slept in days. Your limbs feel heavy, as if you are moving through molasses, and the mental effort required to simply plan your day feels akin to solving complex calculus.  This is not the “tiredness” that follows a long day […]

The post Understanding Parkinson’s Fatigue appeared first on PhotoPharmics.

]]> PhotoPharmics Announces Board Expansion to Support the Next Phases of Growth: Clinical Execution, Commercialization, and Strategic Partnerships https://photopharmics.com/photopharmics-announces-board-expansion-to-support-the-next-phases-of-growth-clinical-execution-commercialization-and-strategic-partnerships/ Thu, 04 Dec 2025 15:00:59 +0000 https://photopharmics.com/?p=6397 The post PhotoPharmics Announces Board Expansion to Support the Next Phases of Growth: Clinical Execution, Commercialization, and Strategic Partnerships appeared first on PhotoPharmics.

]]> The Role of Nutrition in Parkinson’s Disease https://photopharmics.com/the-role-of-nutrition-in-parkinsons-disease/ Mon, 01 Dec 2025 00:33:30 +0000 https://photopharmics.com/?p=6383 Introduction Did you know that unintentional weight loss and nutritional deficiencies are among the most common challenges for people with Parkinson’s disease, often occurring even before a diagnosis is made? In simple terms, Parkinson’s Disease is a condition where the specific brain cells responsible for controlling movement gradually stop working. These cells are supposed to […]

The post The Role of Nutrition in Parkinson’s Disease appeared first on PhotoPharmics.

]]> PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial https://photopharmics.com/photopharmics-surpasses-enrollment-target-with-350-participants-in-first-of-a-kind-remote-home-based-phase-3-light-for-pd-clinical-trial/ Wed, 05 Nov 2025 07:00:49 +0000 https://photopharmics.com/?p=6313 PhotoPharmics, a clinical-stage medical device company pioneering Photo Neuromodulation for neurodegenerative disease, today announced it has surpassed its enrollment target with 350 participants in its pivotal, Phase 3 Light for PD clinical trial evaluating the Celeste® device for people living with Parkinson’s disease.

“Exceeding our target and closing enrollment is a remarkable milestone for the Parkinson’s community,” said Kent Savage, Chief Executive Officer of PhotoPharmics. “We’re proving that rigorous science can be both patient-centered and home-based. We’re deeply grateful to our investigators, study teams, and especially our participants and their families, whose courage and commitment make this work possible.”

The post PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial appeared first on PhotoPharmics.

]]> Young-Onset Parkinson’s: Navigating Your Journey After an Early Diagnosis https://photopharmics.com/young-onset-parkinsons-navigating-your-journey-after-an-early-diagnosis/ Thu, 23 Oct 2025 18:43:56 +0000 https://photopharmics.com/?p=6306 An early diagnosis of Young-Onset Parkinson's Disease (YOPD) presents a unique set of challenges during the prime of your life. This blog serves as a proactive roadmap for navigating your journey, exploring the differences in YOPD symptoms, modern treatment strategies, the critical role of exercise and mental health, and how to manage your career and family life with confidence.

The post Young-Onset Parkinson’s: Navigating Your Journey After an Early Diagnosis appeared first on PhotoPharmics.

]]> PhotoPharmics to Feature Photo Neurostimulation at the 2025 Movement Disorders Society International Congress https://photopharmics.com/photopharmics-to-feature-photo-neurostimulation-at-the-2025-movement-disorders-society-international-congress/ Fri, 03 Oct 2025 14:00:31 +0000 https://photopharmics.com/?p=6296 Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson’s care PhotoPharmics, a clinical-stage medtech device company specializing in non-invasive photo neurostimulation, today announced its participation in the 2025 International Congress of Parkinson’s Disease and Movement Disorders to be held October 5-9 in Honolulu, Hawaii. The company invites attendees to […]

The post PhotoPharmics to Feature Photo Neurostimulation at the 2025 Movement Disorders Society International Congress appeared first on PhotoPharmics.

]]> Understanding and Managing Depression and Anxiety in Parkinson’s https://photopharmics.com/understanding-and-managing-depression-and-anxiety-in-parkinsons/ Fri, 26 Sep 2025 19:20:39 +0000 https://photopharmics.com/?p=6280 Introduction Did you know that at least 50% of people with Parkinson’s Disease (PD) will experience some form of depression during their illness, and up to 40% will face a significant anxiety disorder?  If you’ve been grappling with your mood, you are far from alone. For too long, the conversation around Parkinson’s has focused almost […]

The post Understanding and Managing Depression and Anxiety in Parkinson’s appeared first on PhotoPharmics.

]]> PhotoPharmics Forms Commercial Advisory Board to Guide Market Launch of Breakthrough Parkinson’s Therapy https://photopharmics.com/photopharmics-forms-commercial-advisory-board-to-guide-market-launch-of-breakthrough-parkinsons-therapy/ Thu, 28 Aug 2025 14:00:43 +0000 https://photopharmics.com/?p=6253 The post PhotoPharmics Forms Commercial Advisory Board to Guide Market Launch of Breakthrough Parkinson’s Therapy appeared first on PhotoPharmics.

]]> Why Am I So Exhausted? Is Fatigue Related to Parkinson’s? https://photopharmics.com/why-am-i-so-exhausted-is-fatigue-related-to-parkinsons/ Thu, 28 Aug 2025 02:46:02 +0000 https://photopharmics.com/?p=6242 Introduction If you’re living with Parkinson’s disease (PD), you might have a deeply personal understanding of what fatigue truly means.  It’s a feeling that goes far beyond the simple tiredness you might experience after a long day.  Many describe it in profound terms: an “unrelenting and non-ending tiredness,” a “total absence of energy,” or a […]

The post Why Am I So Exhausted? Is Fatigue Related to Parkinson’s? appeared first on PhotoPharmics.

]]>